Our results demonstrate that the combination therapy not only reduces conventional cancer stem cell markers, including ALDH1 activity, and diminishes tumorsphere formation in both primary and secondary generations, but also significantly suppresses anchorage-independent growth in 3D culture (Figure 6), a functional hallmark of stemness and malignant potential (35). This evidence concerns the gene ALDH1A1 and cancer.